consumer genomics
FDA Clears 23andMe BRCA1/2 Consumer Health Risk Report for 41 Additional Variants
The 510(k) clearance will allow 23andMe to offer breast, ovarian, prostate, and pancreatic cancer risk assessments for a broader range of populations.
Genetic Testing Challenges in Oncology: Doc Tells Patient With Familial Risks to Get DTC Testing
A woman worried about her cancer risks gets tested through 23andMe upon the recommendation of a "holistic doctor" but isn't prepared for what the testing reveals.
23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test
The firm is now authorized to sell a genetic health report on the HOXB13 marker that indicates risk for hereditary prostate cancer, its third DTC cancer risk report with 510(k) clearance.
Genetic Testing Challenges in Oncology: Consumer Genomics Reveals More Than Fun Traits
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.
Genetic Testing Challenges in Oncology: False Positive After Testing at Pop-Up Booth
A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care.